Zhang Qian, Wang Bing-dong, Wang Jie-ping, Zhao Ya-yuan, Sun Xiao-wei, Hao Jin-rui, He Zhi-song
Department of Urology, Peking University First Hospital, Beijing 100034, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2009 Dec 18;41(6):687-90.
To determine the diagnostic value of multislice CT urography (MSCTU) in patients with transitional cell carcinoma (TCC) of upper urinary tract by comparing other imageology methods used.
Two hundred and thirty four cases of transitional cell carcinoma of upper urinary tract, in which 82 cases were diagnosed pathologically with pelvic carcinoma and 152 cases with ureteral carcinoma, between June 2004 and September 2006 in our institute were enrolled in a retrospective study. Most of them underwent urological ultrasound, intravenous urogram (IVU), retrograde pyelography and MSCTU. We compared the positive rate (PR) and diagnostic rate (DR) of these methods used by chi-square test.
Among the 234 cases, 215 patients underwent urologic ultrasound, in which 152 cases were detected to be abnormal, with the PR of 70.7%; Meanwhile, 58 cased were diagnosed by this examination, with the DR of 27.0%. IVU was performed in 193 patients and 132 cases were found to be abnormal, and the PR was 68.4%, 65 cases were diagnosed by IVU and the DR was 33.7%. And 132 patients underwent retrograde pyelography, by which 115 cases of lesion were detected, with the PR of 87.1%; In the meantime, 93 cases were diagnosed, with the DR of 70.5%. MSCTU was performed in 226 cases and 220 cases were found to be abnormal, and the PR was 97.3%; 214 cases were diagnosed by MSCTU, with the DR of 94.7%. The DR of detecting TCC of retrograde pyelography had statistically significant difference with that of ultrasound and IVU (P<0.001). As compared with retrograde pyelography, MSCTU had statistically significant superiority (P<0.001).
To shorten the diagnosis time and mitigate the sufferings, patients with hematuria supposed to be TCC of upper urinary tract should be recommended to undergo MSCTU first.
通过比较其他影像学检查方法,确定多层螺旋CT尿路造影(MSCTU)在上尿路移行细胞癌(TCC)患者中的诊断价值。
回顾性分析2004年6月至2006年9月我院收治的234例上尿路移行细胞癌患者,其中82例经病理诊断为肾盂癌,152例为输尿管癌。大多数患者接受了泌尿外科超声、静脉肾盂造影(IVU)、逆行肾盂造影和MSCTU检查。我们采用卡方检验比较这些检查方法的阳性率(PR)和诊断率(DR)。
234例患者中,215例接受了泌尿外科超声检查,其中152例检测异常,PR为70.7%;同时,该检查诊断出58例,DR为27.0%。193例患者进行了IVU检查,132例发现异常,PR为68.4%,IVU诊断出65例,DR为33.7%。132例患者接受了逆行肾盂造影,检测出115例病变,PR为87.1%;同时,诊断出93例,DR为70.5%。226例患者进行了MSCTU检查,220例发现异常,PR为97.3%;MSCTU诊断出214例,DR为94.7%。逆行肾盂造影检测TCC的DR与超声和IVU相比有统计学差异(P<0.001)。与逆行肾盂造影相比,MSCTU具有统计学上的显著优势(P<0.001)。
为缩短诊断时间并减轻患者痛苦,对于疑似上尿路TCC血尿患者,建议首先进行MSCTU检查。